Hunan Jiudian Pharmaceutical Co., Ltd. (HUNAN JIUDIAN PHARMACEUTICAL CO) aksje
300705.SZ
Forsinket 15 minHUNAN JIUDIAN PHARMACEUTICAL CO
Market Cap
$5,818,385,920
Om Hunan Jiudian Pharmaceutical Co., Ltd. (HUNAN JIUDIAN PHARMACEUTICAL CO) aksje
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and breathing and anti-allergy. In addition, it provides CMO/CDMO services. The company was founded in 2001 and is based in Changsha, China.
Selskapsinformasjon
410205 Changsha, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.